In situ treatment of dense nonaqueous phase liquids.
NASA seeks to license the NASA-developed technology Emulsified Zero-Valent Iron (EZVI) for use in commercial applications. Developed at the John F. Kennedy Space Center (KSC), this process provides for the in situ treatment of dense nonaqueous phase liquids, or DNAPLs. This technology is one of the few methods available that can treat the DNAPL source. EZVI also overcomes the limitations of current DNAPL treatment technologies by providing a method that is quick, effective, and cost-competitive. EZVI is part of NASA’s technology transfer program. This program seeks to promote the commercial use of NASA-developed technologies.